Acquired multicellular-mediated resistance to alkylating agents in cancer
about
Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transportersChanges in P-glycoprotein activity are mediated by the growth of a tumour cell line as multicellular spheroidsBioengineering Models for Breast Cancer ResearchFeasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative ReviewMass spectrometry imaging of therapeutics from animal models to three-dimensional cell culturesCell-cell and cell-matrix dynamics in intraperitoneal cancer metastasisRole of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate CancerSensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrixA multifunctional mesothelin antibody-tagged microparticle targets human mesotheliomasA 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug developmentHigh-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cellsOptimization of Aqueous Biphasic Tumor Spheroid Microtechnology for Anti-Cancer Drug Testing in 3D CultureInduction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroidsThe fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cellsIdentification of agents that induce apoptosis of multicellular tumour spheroids: enrichment for mitotic inhibitors with hydrophobic properties.Multiplexed, high-throughput analysis of 3D microtissue suspensions.A microfluidic system for investigation of extravascular transport and cellular uptake of drugs in tumors.Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiationSense and sensibility: the use of cell death biomarker assays in high-throughput anticancer drug screening and monitoring treatment responses.Three-dimensional culture regulates Raf-1 expression to modulate fibronectin matrix assemblyIntegrins and extracellular matrix: a novel mechanism of multidrug resistance.Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expressionNeural stem cells transplantation alleviate the hyperalgesia of spinal cord injured (SCI) associated with down-regulation of BDNFGap junction enhances phototoxicity of photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH).Tumor-Endothelial Cell Three-dimensional Spheroids: New Aspects to Enhance Radiation and Drug TherapeuticsGene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents.Homo sapiens systemic RNA interference-defective-1 transmembrane family member 1 (SIDT1) protein mediates contact-dependent small RNA transfer and microRNA-21-driven chemoresistance.Regulation of carcinoembryonic antigen expression in human colon carcinoma cells by the organ microenvironment.High-Throughput Cancer Cell Sphere Formation for Characterizing the Efficacy of Photo Dynamic Therapy in 3D Cell Cultures.Spheroid assay to measure TGF-β-induced invasion.Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid TumorsCan mosaic tumor vessels facilitate molecular diagnosis of cancer?Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell LinesApoptosis induced by inhibition of intercellular contactMassive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expressionEvolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancerNew insights into the kinetic resistance to anticancer agentsE-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)
P2860
Q24648348-DAA50AEA-6BE2-4825-BC09-7890D3B814C0Q24812918-DC8E231E-7643-4253-B528-F1C6296BEB5EQ26770495-3618D744-8021-4778-BB47-2E12D9D3B22AQ26783599-3D742AFE-7626-423F-A305-76B86B666C81Q26820859-C3BC2C0B-0B6D-4C05-AC6A-F7C3D3F1BAE9Q26851836-1700944E-1859-490D-B7F6-0345996F8065Q28075965-0292C048-93FC-4A52-A9AC-A4DF2E1EE3B1Q28386738-8B2F392F-B180-4642-9EB5-E64B3511F9AFQ28392105-BAC0784C-8DE3-4AB4-BF01-B1B1BA448B23Q28534459-934F921D-FC11-4C10-90C7-CA1EBB1CCCBAQ28534624-446F73A6-6488-4774-AE8D-CBD3DA442E8AQ30403638-3B565828-6FCE-4157-8B0F-006B2A52DB31Q30442799-DE706DDF-F49F-4635-AF60-2895D0C79BD1Q33321330-2039A9B4-8506-44A0-9504-128A04DD3D66Q33372937-3BA79AEE-3183-48AD-9F84-469E18D79D38Q33949865-A857424A-6216-4624-9F0D-1D6AB75F91BDQ34014722-8765BF1D-6452-487B-9C5B-A687552ED5D3Q34085441-99BACDC4-58FE-4CC0-BAD8-A074207DB100Q34292287-779DBDE3-7DA1-436B-A9C7-A6D0F28C59D1Q34405013-65290FFF-D163-4C35-8F48-B8193D2BECD8Q34626314-4F64D068-8FE0-4072-A5FA-5A311012D3F1Q34885960-CA12DCB0-CC3E-423A-AA82-EB0442EADADBQ35089143-83E8CBB5-F6A4-48CD-A234-0E39FEA79609Q35149179-D5F9E7D8-FD18-4F77-8CE9-6ABA23594E54Q35173472-4EC734B9-9693-48F4-92E9-9AB89810C58EQ35498592-5AC5B01F-0CB7-4608-A2A7-6905D233D9CEQ35626527-A70884C9-EAF8-4E3F-84B7-564FBFCE7F81Q35663759-E7233D8F-1FDE-4320-B5F0-3E12E8D63A52Q35773897-54985C3F-93ED-4878-8BA0-A7BD79C797DFQ35782244-3456C1D7-C5A7-4FD0-B1F9-2962EE032D12Q35830253-471842BB-3E08-401E-BAEC-781AF23C375AQ35841546-842BE264-895A-4495-B94D-A2ED5843C473Q35845149-51B9F572-96FC-4D99-B9DC-301D97F772EEQ35911771-EB6F3D2C-7979-4B5F-B49A-919EFA008333Q35974087-A55480B6-605E-45FE-9DC5-99F541866A1AQ36234206-5D93C033-9860-428A-BE3A-F57C66F58B97Q36236394-A2F0628C-88F2-4284-9178-04B94D408278Q36241242-97515A8C-6C38-4835-AA45-5DDA8B896CB4Q36254839-3E0F2BD4-DD99-41BA-BAF2-8989011966ECQ36256290-F9C5BB7E-9FAA-4E77-9FB5-2AEA1CB318AC
P2860
Acquired multicellular-mediated resistance to alkylating agents in cancer
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Acquired multicellular-mediated resistance to alkylating agents in cancer
@ast
Acquired multicellular-mediated resistance to alkylating agents in cancer
@en
type
label
Acquired multicellular-mediated resistance to alkylating agents in cancer
@ast
Acquired multicellular-mediated resistance to alkylating agents in cancer
@en
prefLabel
Acquired multicellular-mediated resistance to alkylating agents in cancer
@ast
Acquired multicellular-mediated resistance to alkylating agents in cancer
@en
P2093
P2860
P356
P1476
Acquired multicellular-mediated resistance to alkylating agents in cancer
@en
P2093
B A Teicher
C H Graham
H Kobayashi
R S Kerbel
S J Kapitain
P2860
P304
P356
10.1073/PNAS.90.8.3294
P407
P577
1993-04-01T00:00:00Z